Protocol summary

Study aim
Comparison of the effect of oral Oxycodone versus intravenous Ketorolac on post laparoscopic cholecystectomy pain
Design
Double blinded randomized clinical trial
Settings and conduct
60 patients referred to Loghman Hospital operating room will be divided into 2 groups: receiving oxycodone or ketorolac. Before induction of anesthesia the former group receive 30 mg of oral oxycodone, while 30 mg ketorolac in 100cc normal saline is administered to the latter intravenously over 30 minutes.Postoperative pain scores are measured and documented based on NRS.
Participants/Inclusion and exclusion criteria
Inclusion Criteria Patients candidate for elective laparoscopic cholecystectomy Age between 18-65 year No history of drug abuse No history of psychologic disease No history of sensitivity to drugs in study Exclusion Criteria    
Intervention groups
Oxycodone group: In addition to routine analgesics, patients receive oral oxycodone to the control postoperative pain. Ketorolac group: In addition to routine analgesics, patients receive intravenous ketorolac to the control postoperative pain.
Main outcome variables
Severity of postoperative pain

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20181216041991N1
Registration date: 2019-01-23, 1397/11/03
Registration timing: registered_while_recruiting

Last update: 2019-01-23, 1397/11/03
Update count: 0
Registration date
2019-01-23, 1397/11/03
Registrant information
Name
masoud nashibi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 5542 4040
Email address
masoudnashibi@sbmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2019-01-10, 1397/10/20
Expected recruitment end date
2019-02-19, 1397/11/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the effect of oral Oxycodone versus intravenous Ketorolac on post laparoscopic cholecystectomy pain
Public title
Comparison of the effect of oral Oxycodone versus intravenous Ketorolac on post laparoscopic cholecystectomy pain
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Patients candidate for laparoscopic cholecystectomy Age between 18-65 year
Exclusion criteria:
No history of drug abuse No history of psychologic disease No allergy to studied drugs No pregnancy and lactation No clinical sign due to sepsis or other inflammatory disease No history of liver and renal failure No history of GI bleeding No history of coagulopathies No history of sign of neuropathy No diagnosis of gangrenous cholecystitis No diagnosis of generalized peritonitis
Age
From 18 years old to 65 years old
Gender
Both
Phase
3
Groups that have been masked
  • Care provider
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 60
Actual sample size reached: 60
Randomization (investigator's opinion)
Randomized
Randomization description
Sealed envelop method
Blinding (investigator's opinion)
Double blinded
Blinding description
Researcher open the pockets confidentially to learn the patient's group. The patients pain scores and other results are documented by an unaware personnel.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Shahid Beheshti University of Medical Sciences
Street address
7th Floor, Bldg No.2 SBUMS, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
19839-63113
Approval date
2019-01-06, 1397/10/16
Ethics committee reference number
IR.SBMU.RETECH.REC.1397.837

Health conditions studied

1

Description of health condition studied
The effect of medications on post laparoscopic cholecystectomy pain
ICD-10 code
ICD-10 code description

Primary outcomes

1

Description
Postoperative pain
Timepoint
1,2,4,6,12 hours postoperative
Method of measurement
Numerical rating Scale;The NRS is a 10 cm horizontal bar which is divided to 0-10 pieces. Respondent selects a whole number (0–10 integers) that best reflects the intensity of his/her pain. Number zero eqauals no pain, while number ten means unbearable pain.

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: In the first group patients receive 30 mg of oral oxycodone before anesthesia induction.
Category
Treatment - Drugs

2

Description
Intervention group: In the second group before anesthesia induction patients receive 30 mg of intravenous ketorolac dissolved in 100 ml normal saline in 30 minute.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
loghman hakim hospital
Full name of responsible person
Masoud nashibi
Street address
South kargar street, kamali street,loghman hakim hospital
City
Tehran
Province
Tehran
Postal code
1333635445
Phone
+98 21 5542 4040
Email
masoudnashibi@sbmu.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Afshin Zarghi
Street address
7th Floor, Bldg No.2 SBUMS, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran, Iran
City
tehran
Province
Tehran
Postal code
19839-63113
Phone
+98 21 2243 9770
Email
msp@sbmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shahid Beheshti University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Masoud Nashibi
Position
Anesthesiologist
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Loghman Hospital, Kamali street, South Kargar street, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1333635445
Phone
+98 21 5542 4040
Fax
+98 21 5542 4040
Email
masoudnashibi@sbmu.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Masoud Nashibi
Position
Anesthesiologist
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Loghman Hospital, Kamali street, South Kargar street, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1333635445
Phone
+98 21 5542 4040
Fax
+98 21 5542 4040
Email
masoudnashibi@sbmu.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Masoud Nashibi
Position
Anesthesiologist
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Loghman Hospital, Kamali street, South Kargar street, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1333635445
Phone
+98 21 5542 4040
Fax
+98 21 5542 4040
Email
masoudnashibi@sbmu.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...